Evidence map›Paper›PMID 42103388›Full record

ArticleBMJ open2026

Risk factors and population attributable fraction for large-for-gestational-age and macrosomic births in low- and middle-income countries between 2000 and 2025: a protocol for systematic review and meta-analysis.

Fati Kirakoya-Samadoulougou, Hannah Blencowe, Dieudonné Ilboudo, Joyeuse Ukwishaka, Lorena Suarez Idueta, Elizabeth A Hazel, Eric Ohuma, Daniel J Erchick, Joanne Katz, Anne Cc Lee and 1 more

Abstract read
In one paragraph

Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fati Kirakoya-SamadoulougouCentre de Recherche en Epidémiologie, Biostatistique et Recherche Clinique, Université libre de Bruxelles, Brussels, Belgium fati.kirakoya@ulb.be.ORCID http://orcid.org/0000-0002-9584-6329
Hannah BlencoweDepartment of Infectious Disease Epidemiology and International Health, Faculty of Epidemiology and Population Health, LSHTM, London, UK.
Dieudonné IlboudoCentre de Recherche en Epidémiologie, Biostatistique et Recherche Clinique, Université libre de Bruxelles, Brussels, Belgium.
Joyeuse UkwishakaCentre de Recherche en Epidémiologie, Biostatistique et Recherche Clinique, Université libre de Bruxelles, Brussels, Belgium.
Lorena Suarez IduetaDepartment of Infectious Disease Epidemiology and International Health, Faculty of Epidemiology and Population Health, LSHTM, London, UK.
Elizabeth A HazelDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.ORCID http://orcid.org/0000-0002-9176-3278
Eric OhumaDepartment of Infectious Disease Epidemiology and International Health, Faculty of Epidemiology and Population Health, LSHTM, London, UK.ORCID http://orcid.org/0000-0002-3116-2593
Daniel J ErchickDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.ORCID http://orcid.org/0000-0002-2852-280X
Joanne KatzDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Anne Cc LeeWarren Alpert Medical School and Global Alliance for Infant and Maternal Health Research, Brown University, Providence, Rhode Island, USA.
Robert E BlackDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLarge-for-gestational-age (LGA) and macrosomic births pose significant maternal and neonatal health risks, particularly in low- and middle-income countries (LMICs), where access to care are often limited. Despite well-established associations between LGA, macrosomia, and various risk factors, the relative contributions of these factors remain underexplored in LMICs. This study aims to identify risks factors for LGA and macrosomia in LMICs, with an emphasis on modifiable ones, and quantify their population attributable fractions (PAFs). METHODS AND ANALYSIS: A systematic review will be conducted across the following databases: MEDLINE, Scopus and ProQuest Central and regional databases (Africa Index Medicus, Index Medicus for South Asia and Latin America and Caribbean literature of health sciences). Eligible studies will include observational studies, reviews and interventional research conducted between 2000 and 2025 that report on prevalence or association of risk factors for large-for-gestational-age (LGA) and/or macrosomia births in low- and middle-income countries (LMICs). Data extraction will encompass study characteristics, prevalence/incidence estimates, risk factor distributions and measures of association. Quality assessment will be performed by two independent reviewers using the Newcastle-Ottawa Scale for observational cohort, case-control and cross-sectional studies. While Cochrane Risk of Bias Tool will be used for randomised controlled trials and a Measurement Tool to Assess Quality of Systematic Reviews 2 (AMSTAR-2) for systematic reviews and meta-analyses. Meta-analyses using a random-effects model, which accounts for population heterogeneity, will synthesise risk estimates for factors examined in three or more studies from LMICs, up-to-date meta-analysis including all relevant studies identified through our search. Population attributable fractions for individual and combined risk factors will be calculated. ETHICS AND DISSEMINATION: This systematic review will use only previously published information. Ethical approval is therefore not required. The results will be submitted for publication in a peer-reviewed journal and the findings will be presented at international conferences to engage relevant stakeholders including policymakers and public health organisations in LMICs with the aim of informing the development of targeted interventions to reduce the burden of LGA and macrosomia births in the region.

Indexed as

Developing CountriesFetal MacrosomiaFemaleHumansInfant, Large for Gestational AgeInfant, NewbornMeta-Analysis as TopicPregnancyResearch DesignRisk FactorsSystematic Reviews as TopicCommunity child healthMeta-AnalysisMothersRisk Factors

Identifiers

PMID42103388
PMCPMC13157752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.